|
1
|
Feng Z, Xu QS, Qin LZ, Li H, Huang X, Su M
and Han Z: Second primary cancer after index head and neck squamous
cell carcinoma in Northern China. Oral Surg Oral Med Oral Pathol
Oral Radiol. 123:95–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pulte D and Brenner H: Changes in survival
in head and neck cancers in the late 20th and early 21st century: A
period analysis. Oncologist. 15:994–1001. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grégoire V, Lefebvre JL, Licitra L and
Felip E; EHNS-ESMO-ESTRO Guidelines Working Group, : Squamous cell
carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21
(Suppl 5):v184–v186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
ENCODE Project Consortium, Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hangauer MJ, Vaughn IW and McManus MT:
Pervasive transcription of the human genome produces thousands of
previously unidentified long intergenic noncoding RNAs. PLoS Genet.
9:e10035692013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou M, Zhang Z, Zhao H, Bao S, Cheng L
and Sun J: An immune-related six-lncRNA signature to improve
prognosis prediction of glioblastoma multiforme. Mol Neurobiol.
55:3684–3697. 2018.PubMed/NCBI
|
|
8
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou M, Zhang Z, Zhao H, Bao S and Sun J:
A novel lncRNA-focus expression signature for survival prediction
in endometrial carcinoma. BMC Cancer. 18:392018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou M, Zhao H, Wang X, Sun J and Su J:
Analysis of long noncoding RNAs highlights region-specific altered
expression patterns and diagnostic roles in Alzheimer's disease.
Brief Bioinform. Apr 17–2018.Doi: 10.1093/bib/bby021.
|
|
11
|
Guan GF, Zhang DJ, Wen LJ, Xin D, Liu Y,
Yu DJ, Su K, Zhu L, Guo YY and Wang K: Overexpression of lncRNA
H19/miR-675 promotes tumorigenesis in head and neck squamous cell
carcinoma. Int J Med Sci. 13:914–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu B, Liu J, Wang B, Liao X, Cui Z and
Ding N: Association on polymorphisms in LncRNA HOTAIR and
susceptibility to HNSCC in Chinese population. Eur Rev Med
Pharmacol Sci. 22:702–706. 2018.PubMed/NCBI
|
|
13
|
Yu J, Liu Y, Guo C, Zhang S, Gong Z, Tang
Y, Yang L, He Y, Lian Y, Li X, et al: Upregulated long non-coding
RNA LINC00152 expression is associated with progression and poor
prognosis of tongue squamous cell carcinoma. J Cancer. 8:523–530.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Han L, Roebuck P, Diao L, Liu L,
Yuan Y, Weinstein JN and Liang H: TANRIC: An interactive open
platform to explore the function of lncRNAs in cancer. Cancer Res.
75:3728–3737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao
H, Zhong Z and Sun J: Comprehensive analysis of lncRNA expression
profiles reveals a novel lncRNA signature to discriminate
nonequivalent outcomes in patients with ovarian cancer. Oncotarget.
7:32433–32448. 2016.PubMed/NCBI
|
|
17
|
Zhou M, Zhao H, Wang Z, Cheng L, Yang L,
Shi H, Yang H and Sun J: Identification and validation of potential
prognostic lncRNA biomarkers for predicting survival in patients
with multiple myeloma. J Exp Clin Cancer Res. 34:1022015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blanche P, Dartigues JF and Jacqmin-Gadda
H: Estimating and comparing time-dependent areas under receiver
operating characteristic curves for censored event times with
competing risks. Stat Med. 32:5381–5397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moreno-Betancur M, Sadaoui H, Piffaretti C
and Rey G: Survival analysis with multiple causes of death:
Extending the competing risks model. Epidemiology. 28:12–19. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cancer Genome Atlas Network: Comprehensive
genomic characterization of head and neck squamous cell carcinomas.
Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung CH, Parker JS, Karaca G, Wu J,
Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X,
et al: Molecular classification of head and neck squamous cell
carcinomas using patterns of gene expression. Cancer Cell.
5:489–500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldman R, Gatalica Z, Knezetic J, Reddy
S, Nathan CA, Javadi N and Teknos T: Molecular profiling of head
and neck squamous cell carcinoma. Head Neck. 38 (Suppl
1):E1625–E1638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramdas L, Giri U, Ashorn CL, Coombes KR,
El-Naggar A, Ang KK and Story MD: miRNA expression profiles in head
and neck squamous cell carcinoma and adjacent normal tissue. Head
Neck. 31:642–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao W, Liu JN, Liu Z, Wang X, Han ZG, Ji
T, Chen WT and Zou X: A three-lncRNA signature derived from the
Atlas of ncRNA in cancer (TANRIC) database predicts the survival of
patients with head and neck squamous cell carcinoma. Oral Oncol.
65:94–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZL, Zhao LJ, Chai L, Zhou SH, Wang
F, Wei Y, Xu YP and Zhao P: Seven LncRNA-mRNA based risk score
predicts the survival of head and neck squamous cell carcinoma. Sci
Rep. 7:3092017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Behrens J: The role of cell adhesion
molecules in cancer invasion and metastasis. Breast Cancer Res
Treat. 24:175–184. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Howell GM and Grandis JR: Molecular
mediators of metastasis in head and neck squamous cell carcinoma.
Head Neck. 27:710–717. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Varilla V, Atienza J and Dasanu CA: Immune
alterations and immunotherapy prospects in head and neck cancer.
Expert Opin Biol Ther. 13:1241–1256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Economopoulou P, Perisanidis C, Giotakis
EI and Psyrri A: The emerging role of immunotherapy in head and
neck squamous cell carcinoma (HNSCC): Anti-tumor immunity and
clinical applications. Ann Transl Med. 4:1732016. View Article : Google Scholar : PubMed/NCBI
|
